{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:57:16Z","timestamp":1790121436994,"version":"4.0.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.autrev.2025.103811","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:17:08Z","timestamp":1744150628000},"page":"103811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Molecular\/antigenic mimicry and immunological cross-reactivity explains SARS-CoV-2-induced autoimmunity"],"prefix":"10.1016","volume":"24","author":[{"given":"Yekbun","family":"Adiguzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitros P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.autrev.2025.103811_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28538","article-title":"Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity","volume":"95","author":"Baiocchi","year":"2023","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103811_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103310","article-title":"Autoantibodies targeting G protein-coupled receptors: an evolving history in autoimmunity. Report of the 4th international symposium","volume":"22","author":"Cabral-Marques","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103811_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841126","article-title":"Autoantibodies against proteins previously associated with autoimmunity in adult and pediatric patients with COVID-19 and children with MIS-C","volume":"13","author":"Burbelo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103811_bb0020","series-title":"SARS-CoV-2 infection induces the production of autoantibodies in severe COVID-19 patients in an age-dependent manner [Internet]","author":"Fonseca","year":"2022"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41514-023-00118-0","article-title":"Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach","volume":"9","author":"Fonseca","year":"2023","journal-title":"Npj Aging"},{"issue":"570","key":"10.1016\/j.autrev.2025.103811_bb0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.autrev.2025.103811_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010118","article-title":"Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins. Ellebedy A, edit\u00f6r","volume":"17","author":"Emmenegger","year":"2021","journal-title":"PLoS Pathog"},{"issue":"21","key":"10.1016\/j.autrev.2025.103811_bb0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200413119","article-title":"The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies","volume":"119","author":"Manry","year":"2022","journal-title":"Proc Natl Acad Sci"},{"issue":"62","key":"10.1016\/j.autrev.2025.103811_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.autrev.2025.103811_bb0050","article-title":"Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19","volume":"4","author":"Anaya","year":"2021","journal-title":"J Transl Autoimmun"},{"issue":"8","key":"10.1016\/j.autrev.2025.103811_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0167-5699(00)01679-0","article-title":"Cross-reactivity and polyreactivity: the two sides of a coin","volume":"21","author":"Bouvet","year":"2000","journal-title":"Immunol Today"},{"issue":"10","key":"10.1016\/j.autrev.2025.103811_bb0060","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1110\/ps.03172703","article-title":"The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness","volume":"12","author":"James","year":"2003","journal-title":"Protein Sci"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001228","article-title":"Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"7","author":"Catrina","year":"2021","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.autrev.2025.103811_bb0070","doi-asserted-by":"crossref","first-page":"2250210","DOI":"10.1002\/eji.202250210","article-title":"Discriminating promiscuous from target-specific autoantibodies in COVID-19","volume":"53","author":"Lebedin","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2025.103811_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.868724","article-title":"Antigenic cross-reactivity between SARS-CoV-2 S1-RBD and its receptor ACE2","volume":"13","author":"Lai","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103811_bb0080","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.biopsych.2022.09.007","article-title":"Anti-SARS-CoV-2 and autoantibody profiling of a COVID-19 patient with subacute psychosis who remitted after treatment with intravenous immunoglobulin","volume":"93","author":"McAlpine","year":"2023","journal-title":"Biol Psychiatry"},{"issue":"8025","key":"10.1016\/j.autrev.2025.103811_bb0085","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41586-024-07722-4","article-title":"Molecular mimicry in multisystem inflammatory syndrome in children","volume":"632","author":"Bodansky","year":"2024","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.autrev.2025.103811_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae370","article-title":"RCSB protein Data Bank: exploring protein 3D similarities via comprehensive structural alignments. Elofsson A, edit\u00f6r","volume":"40","author":"Bittrich","year":"2024","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.autrev.2025.103811_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.autrev.2025.103811_bb0100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/micmic\/ozac036","article-title":"Structural insights of the SARS-CoV-2 nucleocapsid protein: implications for the inner-workings of rapid antigen tests","volume":"29","author":"Casasanta","year":"2023","journal-title":"Microsc Microanal"},{"key":"10.1016\/j.autrev.2025.103811_bb0105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81702","article-title":"Structure of SARS-CoV-2 M protein in lipid nanodiscs","volume":"11","author":"Dolan","year":"2022","journal-title":"eLife"},{"issue":"D1","key":"10.1016\/j.autrev.2025.103811_bb0110","doi-asserted-by":"crossref","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.autrev.2025.103811_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbi.2020.12.022","article-title":"High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms","volume":"93","author":"Franke","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12974-021-02293-x","article-title":"Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases","volume":"18","author":"Vasilevska","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2025.103811_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0130","doi-asserted-by":"crossref","first-page":"13946","DOI":"10.1038\/s41598-018-32193-9","article-title":"Epitopes identified in GAPDH from Clostridium difficile recognized as common antigens with potential autoimmunizing properties","volume":"8","author":"Razim","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2025.103811_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.617089","article-title":"Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases","volume":"11","author":"Vojdani","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103811_bb0140","article-title":"Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity","volume":"3","author":"Lyons-Weiler","year":"2020","journal-title":"J Transl Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2025.103811_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103012","article-title":"Autoantibodies and SARS-CoV2 infection: the spectrum from association to clinical implication: report of the 15th Dresden symposium on autoantibodies","volume":"21","author":"Damoiseaux","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0150","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","article-title":"New-onset IgG autoantibodies in hospitalized patients with COVID-19","volume":"12","author":"Chang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103811_bb0155","series-title":"Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19 [Internet]","author":"Jernbom Falk","year":"2024"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0160","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1038\/s41467-024-53356-5","article-title":"Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19","volume":"15","author":"Jernbom","year":"2024","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.autrev.2025.103811_bb0165","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169515","article-title":"Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients","volume":"8","author":"Bodansky","year":"2023","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.autrev.2025.103811_bb0170","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.cels.2021.08.008","article-title":"Human plasma IgG1 repertoires are simple, unique, and dynamic","volume":"12","author":"Bondt","year":"2021","journal-title":"Cell Syst"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916934.2019.1581774","article-title":"Individual and stable autoantibody repertoires in healthy individuals","volume":"52","author":"Neiman","year":"2019","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103811_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.866407","article-title":"An HLA map of the world: a comparison of HLA frequencies in 200 worldwide populations reveals diverse patterns for class I and class II","volume":"14","author":"Arrieta-Bola\u00f1os","year":"2023","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0185","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s12967-021-03184-8","article-title":"Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection","volume":"19","author":"Liu","year":"2021","journal-title":"J Transl Med"},{"issue":"7866","key":"10.1016\/j.autrev.2025.103811_bb0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2025.103811_bb0195","series-title":"Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course [Internet]","author":"Muri","year":"2022"},{"issue":"4","key":"10.1016\/j.autrev.2025.103811_bb0200","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41590-023-01445-w","article-title":"Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course","volume":"24","author":"Muri","year":"2023","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103811_bb0205","doi-asserted-by":"crossref","first-page":"182","DOI":"10.31662\/jmaj.2020-0019","article-title":"Targeting the chemokine system in rheumatoid arthritis and vasculitis","volume":"3","author":"Miyabe","year":"2020","journal-title":"JMA J"},{"key":"10.1016\/j.autrev.2025.103811_bb0210","doi-asserted-by":"crossref","first-page":"1100869","DOI":"10.3389\/fimmu.2023.1100869","article-title":"Chemokines and chemokine receptors as promising targets in rheumatoid arthritis","volume":"13","author":"Murayama","year":"2023","journal-title":"Front Immunol"},{"issue":"6515","key":"10.1016\/j.autrev.2025.103811_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.autrev.2025.103811_bb0220","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10875-021-01060-0","article-title":"Neutralizing autoantibodies to type I interferons in COVID-19 convalescent donor plasma","volume":"41","author":"Vazquez","year":"2021","journal-title":"J Clin Immunol"},{"issue":"612","key":"10.1016\/j.autrev.2025.103811_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"Van Der Wijst","year":"2021","journal-title":"Sci Transl Med"},{"issue":"7934","key":"10.1016\/j.autrev.2025.103811_bb0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-022-05273-0","article-title":"Dysregulated naive B cells and de novo autoreactivity in severe COVID-19","volume":"611","author":"Woodruff","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.autrev.2025.103811_bb0235","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/cid\/ciab890","article-title":"Lack of antinuclear antibodies in convalescent coronavirus disease 2019 patients with persistent symptoms","volume":"74","author":"Peluso","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.autrev.2025.103811_bb0240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/vaccines12050539","article-title":"In silico and in vitro evaluation of the molecular mimicry of the SARS-CoV-2 spike protein by common short constituent sequences (cSCSs) in the human proteome: toward safer epitope design for vaccine development","volume":"12","author":"Mizuno","year":"2024","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.autrev.2025.103811_bb0245","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2174\/092986652012131112121417","article-title":"Structural characteristics of short peptides in solution","volume":"20","author":"Ohtake","year":"2013","journal-title":"Protein Pept Lett"},{"issue":"15","key":"10.1016\/j.autrev.2025.103811_bb0250","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1021\/ja037980i","article-title":"\u03b1-turn mimetics: short peptide \u03b1-helices composed of cyclic metallopentapeptide modules","volume":"126","author":"Kelso","year":"2004","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0255","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-021-23977-1","article-title":"Immunological imprinting of the antibody response in COVID-19 patients","volume":"12","author":"Aydillo","year":"2021","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.autrev.2025.103811_bb0260","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150613","article-title":"Seasonal coronavirus\u2013specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19","volume":"131","author":"Aguilar-Bretones","year":"2021","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1016\/j.autrev.2025.103811_bb0265","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156372","article-title":"Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses","volume":"7","author":"McNaughton","year":"2022","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.autrev.2025.103811_bb0270","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s10038-020-0808-9","article-title":"SARS-CoV-2 genomic variations associated with mortality rate of COVID-19","volume":"65","author":"Toyoshima","year":"2020","journal-title":"J Hum Genet"},{"issue":"6","key":"10.1016\/j.autrev.2025.103811_bb0275","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/tan.15160","article-title":"HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID -19","volume":"102","author":"Castro-Santos","year":"2023","journal-title":"HLA"},{"issue":"2","key":"10.1016\/j.autrev.2025.103811_bb0280","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14525","article-title":"The relationship between COVID-19 and HLA in kidney transplant recipients, an evaluation of predictive and prognostic factors","volume":"36","author":"Ertosun","year":"2022","journal-title":"Clin Transplant"},{"issue":"11","key":"10.1016\/j.autrev.2025.103811_bb0285","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13661","article-title":"SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1","volume":"51","author":"Pagano","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.autrev.2025.103811_bb0290","doi-asserted-by":"crossref","first-page":"2050654","DOI":"10.1080\/21645515.2022.2050654","article-title":"Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach","volume":"18","author":"Konstantinou","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"13","key":"10.1016\/j.autrev.2025.103811_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108915","article-title":"Linear epitope landscape of the SARS-CoV-2 spike protein constructed from 1,051 COVID-19 patients","volume":"34","author":"Li","year":"2021","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.autrev.2025.103811_bb0300","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41551-022-00925-y","article-title":"Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries","volume":"6","author":"Credle","year":"2022","journal-title":"Nat Biomed Eng"},{"issue":"D1","key":"10.1016\/j.autrev.2025.103811_bb0305","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.autrev.2025.103811_bb0310","doi-asserted-by":"crossref","DOI":"10.1177\/21514593221098828","article-title":"The Covid 19 pandemic effect on the epidemiology of thoracolumbar fractures presenting to the emergency department in patients above 65 years old","volume":"13","author":"Lotan","year":"2022","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0315","first-page":"10","article-title":"A case of post-COVID-19 fibrosis mimicking thoracic manifestation of ankylosing spondylitis","volume":"29","author":"Do\u011fan","year":"2022","journal-title":"Acta Medica Litu"},{"key":"10.1016\/j.autrev.2025.103811_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.634441","article-title":"ERAP2 increases the abundance of a peptide submotif highly selective for the birdshot uveitis-associated HLA-A29","volume":"12","author":"Venema","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103811_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1423","article-title":"Parallel detection of SARS-CoV-2 epitopes reveals dynamic immunodominance profiles of CD8+ T memory cells in convalescent COVID-19 donors","volume":"11","author":"van den Dijssel","year":"2022","journal-title":"Clin Transl Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103811_bb0330","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1074\/mcp.RA119.001524","article-title":"Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma","volume":"18","author":"Shraibman","year":"2019","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0335","doi-asserted-by":"crossref","first-page":"20465","DOI":"10.1038\/s41598-020-77466-4","article-title":"Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools","volume":"10","author":"Prachar","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0340","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/acs.jproteome.1c00842","article-title":"HLA allele-specific quantitative profiling of type 1 diabetic B lymphocyte immunopeptidome","volume":"21","author":"Sudhir","year":"2022","journal-title":"J Proteome Res"},{"issue":"5","key":"10.1016\/j.autrev.2025.103811_bb0345","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01837-20","article-title":"Identification of HLA-A*02:01-restricted candidate epitopes derived from the non-structural polyprotein 1a of SARS-CoV-2 that may be natural targets of CD8+ T cell recognition in vivo","volume":"95","author":"Takagi","year":"2021","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103811_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103934","article-title":"SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response","volume":"25","author":"Xiao","year":"2022","journal-title":"iScience"},{"issue":"17","key":"10.1016\/j.autrev.2025.103811_bb0355","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1016\/j.cell.2021.06.029","article-title":"Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses","volume":"184","author":"Nathan","year":"2021","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.autrev.2025.103811_bb0360","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1074\/jbc.M117.789180","article-title":"The Beh\u00e7et\u2019s disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing","volume":"292","author":"Guasp","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2025.103811_bb0365","article-title":"Immunogenic SARS-CoV2 epitopes defined by mass spectrometry","author":"Pan","year":"2021","journal-title":"BioRxiv Prepr Serv Biol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103811_bb0370","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s43587-023-00379-0","article-title":"Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults","volume":"3","author":"Xiao","year":"2023","journal-title":"Nat Aging"},{"issue":"84","key":"10.1016\/j.autrev.2025.103811_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl8881","article-title":"HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation","volume":"8","author":"Yang","year":"2023","journal-title":"Sci Immunol"},{"issue":"15","key":"10.1016\/j.autrev.2025.103811_bb0380","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1016\/j.cell.2021.05.046","article-title":"Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs","volume":"184","author":"Weingarten-Gabbay","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103811_bb0385","doi-asserted-by":"crossref","first-page":"1151659","DOI":"10.3389\/fimmu.2023.1151659","article-title":"Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8+T cells","volume":"14","author":"Lie-Andersen","year":"2023","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103811_bb0390","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1038\/s41423-021-00784-8","article-title":"Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice","volume":"18","author":"Jin","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103811_bb0395","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.4049\/jimmunol.2001438","article-title":"Genome-wide B cell, CD4+, and CD8+ T cell epitopes that are highly conserved between human and animal coronaviruses, identified from SARS-CoV-2 as targets for preemptive Pan-coronavirus vaccines","volume":"206","author":"Prakash","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103811_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.crstbi.2024.100148","article-title":"The impact of SARS-CoV-2 spike mutation on peptide presentation is HLA allomorph-specific","volume":"7","author":"Ahn","year":"2024","journal-title":"Curr Res Struct Biol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0405","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1038\/s41467-022-32989-4","article-title":"Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine","volume":"13","author":"Kuse","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0410","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1038\/s41467-022-34180-1","article-title":"Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 omicron variants BA.1, BA.2 and BA.3","volume":"13","author":"Swaminathan","year":"2022","journal-title":"Nat Commun"},{"issue":"57","key":"10.1016\/j.autrev.2025.103811_bb0415","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg6461","article-title":"SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses","volume":"6","author":"Agerer","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.autrev.2025.103811_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103610","article-title":"Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and na\u00efve CD8 T cells of unexposed individuals","volume":"72","author":"Quiros-Fernandez","year":"2021","journal-title":"EBioMedicine"},{"issue":"13","key":"10.1016\/j.autrev.2025.103811_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109305","article-title":"Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics","volume":"35","author":"Nagler","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2025.103811_bb0430","article-title":"CD8+ T-cell epitope variations suggest a potential antigen HLA-A2 binding deficiency for spike protein of SARS-CoV-2","volume":"12","author":"Qiu","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103811_bb0435","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/JLB.4MA0621-020R","article-title":"Identification of HLA-A2 restricted CD8+ T cell epitopes in SARS-CoV-2 structural proteins","volume":"110","author":"Deng","year":"2021","journal-title":"J Leukoc Biol"},{"issue":"61","key":"10.1016\/j.autrev.2025.103811_bb0440","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg5669","article-title":"CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients","volume":"6","author":"Mallajosyula","year":"2021","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103811_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102096","article-title":"The presentation of SARS-CoV-2 peptides by the common HLA-A\u221702:01 molecule","volume":"24","author":"Szeto","year":"2021","journal-title":"iScience"},{"issue":"15","key":"10.1016\/j.autrev.2025.103811_bb0450","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.vaccine.2021.03.008","article-title":"Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers","volume":"39","author":"Poluektov","year":"2021","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.autrev.2025.103811_bb0455","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1074\/mcp.M900001-MCP200","article-title":"Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients","volume":"8","author":"Fissolo","year":"2009","journal-title":"Mol Cell Proteomics MCP"},{"issue":"4","key":"10.1016\/j.autrev.2025.103811_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103035","article-title":"Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity","volume":"299","author":"Wu","year":"2023","journal-title":"J Biol Chem"},{"issue":"16","key":"10.1016\/j.autrev.2025.103811_bb0465","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1016\/j.cell.2022.07.002","article-title":"Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope","volume":"185","author":"Dolton","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.autrev.2025.103811_bb0470","doi-asserted-by":"crossref","first-page":"e02002","DOI":"10.1128\/JVI.02002-20","article-title":"Identification of SARS-CoV-2 nucleocapsid and spike T-cell epitopes for assessing T-cell immunity","volume":"95","author":"Lee","year":"2021","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103811_bb0475","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/v16010052","article-title":"Ad5-nCoV vaccination could induce HLA-E restricted CD8+ T cell responses specific for epitopes on severe acute respiratory syndrome coronavirus 2 spike protein","volume":"16","author":"Wang","year":"2023","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.autrev.2025.103811_bb0480","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12016-023-08962-4","article-title":"Shared pathogenicity features and sequences between EBV, SARS-CoV-2, and HLA class I molecule-binding motifs with a potential role in autoimmunity","volume":"65","author":"Adiguzel","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2025.103811_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108426","article-title":"On the molecular determinants of the SARS-CoV-2 attack","volume":"215","author":"Kanduc","year":"2020","journal-title":"Clin Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:05:26Z","timestamp":1762553126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":97,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1568997225000710"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103811","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular\/antigenic mimicry and immunological cross-reactivity explains SARS-CoV-2-induced autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103811"}}